Thomas J Herzog

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma
    Stephanie L Wethington
    Columbia University College of Physician and Surgeons, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 161 Fort Washington Ave, 8th Floor, Room 838, New York, NY 10032, USA
    Expert Rev Anticancer Ther 8:819-31. 2008
  2. doi request reprint A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
    Thomas J Herzog
    Columbia University, NY Presbyterian Medical Center, New York, NY, USA Electronic address
    Gynecol Oncol 132:517-25. 2014
  3. ncbi request reprint Unmet needs in ovarian cancer: dividing histologic subtypes to exploit novel targets and pathways
    Vijaya Galic
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, 161 Ft Washington Avenue, New York, NY 10032, USA
    Curr Cancer Drug Targets 13:698-707. 2013
  4. doi request reprint A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma
    Thomas J Herzog
    Columbia University and NY Presbyterian Hospital, New York, NY 10032, USA
    Gynecol Oncol 130:25-30. 2013
  5. ncbi request reprint The impact of cervical cancer on quality of life--the components and means for management
    Thomas J Herzog
    Columbia University, Obstetrics and Gynecology Department, 161 Fort Washington Ave, 8th Floor, Room 838, New York, NY 10032, USA
    Gynecol Oncol 107:572-7. 2007
  6. doi request reprint Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
    Thomas J Herzog
    Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 122:350-5. 2011
  7. ncbi request reprint Ovarian cancer: a focus on management of recurrent disease
    Thomas J Herzog
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University, Herbert Irving Cancer Center, 161 Ft Washington Avenue, New York, NY 10032, USA
    Nat Clin Pract Oncol 3:604-11. 2006
  8. doi request reprint Initial lessons learned in HPV vaccination
    Thomas J Herzog
    Columbia University, College of Physicians and Surgeons, Department of Obstetrics and Gynecology, 161 Fort Washington Avenue, 8th Floor New York, NY 10032, USA
    Gynecol Oncol 109:S4-11. 2008
  9. ncbi request reprint The current treatment of recurrent ovarian cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University, Herbert Irving Cancer Center, New York, NY 10032, USA
    Curr Oncol Rep 8:448-54. 2006
  10. ncbi request reprint Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 103:637-41. 2006

Detail Information

Publications133 found, 100 shown here

  1. doi request reprint Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma
    Stephanie L Wethington
    Columbia University College of Physician and Surgeons, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 161 Fort Washington Ave, 8th Floor, Room 838, New York, NY 10032, USA
    Expert Rev Anticancer Ther 8:819-31. 2008
    ..Conclusions include a discussion of future avenues of research and ongoing projects...
  2. doi request reprint A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube
    Thomas J Herzog
    Columbia University, NY Presbyterian Medical Center, New York, NY, USA Electronic address
    Gynecol Oncol 132:517-25. 2014
    ..To determine the safety and efficacy of the novel combination of docetaxel, oxaliplatin, and bevacizumab as first-line treatment of advanced cancer of the ovary, peritoneum or fallopian tube after initial debulking surgery...
  3. ncbi request reprint Unmet needs in ovarian cancer: dividing histologic subtypes to exploit novel targets and pathways
    Vijaya Galic
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center, 161 Ft Washington Avenue, New York, NY 10032, USA
    Curr Cancer Drug Targets 13:698-707. 2013
    ....
  4. doi request reprint A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma
    Thomas J Herzog
    Columbia University and NY Presbyterian Hospital, New York, NY 10032, USA
    Gynecol Oncol 130:25-30. 2013
    ..A double-blind, randomized, placebo-controlled, phase II study to assess the efficacy and safety of maintenance therapy with sorafenib in the treatment of OC is presented...
  5. ncbi request reprint The impact of cervical cancer on quality of life--the components and means for management
    Thomas J Herzog
    Columbia University, Obstetrics and Gynecology Department, 161 Fort Washington Ave, 8th Floor, Room 838, New York, NY 10032, USA
    Gynecol Oncol 107:572-7. 2007
    ..To review how cervical cancer patients are affected on a psychological, psychosocial, and sexual level, resulting in an overall decrease in quality of life (QoL)...
  6. doi request reprint Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
    Thomas J Herzog
    Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 122:350-5. 2011
    ....
  7. ncbi request reprint Ovarian cancer: a focus on management of recurrent disease
    Thomas J Herzog
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University, Herbert Irving Cancer Center, 161 Ft Washington Avenue, New York, NY 10032, USA
    Nat Clin Pract Oncol 3:604-11. 2006
    ..The sequence, combinations of treatment, and manner in which any or all of these options should be employed in an individual patient, which heretofore have not been standardized, are the subjects of ongoing clinical investigations...
  8. doi request reprint Initial lessons learned in HPV vaccination
    Thomas J Herzog
    Columbia University, College of Physicians and Surgeons, Department of Obstetrics and Gynecology, 161 Fort Washington Avenue, 8th Floor New York, NY 10032, USA
    Gynecol Oncol 109:S4-11. 2008
    ..This article also examines the impact of the HPV vaccination awareness campaign on media and public policy dynamics...
  9. ncbi request reprint The current treatment of recurrent ovarian cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University, Herbert Irving Cancer Center, New York, NY 10032, USA
    Curr Oncol Rep 8:448-54. 2006
    ..It is hoped that the results of future and ongoing clinical trials will offer further advances in the treatment of this devastating disease...
  10. ncbi request reprint Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 103:637-41. 2006
    ..To assess the efficacy and toxicity profile in patients treated with topotecan at 2.0 mg/m2/day x 3 days every 3 weeks...
  11. ncbi request reprint Recurrent ovarian cancer: how important is it to treat to disease progression?
    Thomas J Herzog
    Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA
    Clin Cancer Res 10:7439-49. 2004
    ....
  12. doi request reprint A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q)
    Thomas J Herzog
    Columbia University, New York Presbyterian Hospital, Department of Ob Gyn, New York, NY 10032, USA
    Gynecol Oncol 120:454-8. 2011
    ..To evaluate the efficacy and safety of topotecan in patients with recurrent ovarian, primary peritoneal, and fallopian tube carcinomas...
  13. ncbi request reprint A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy
    Thomas J Herzog
    Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 195:445-53. 2006
    ..The purpose of this study was to investigate the safety and efficacy of alvimopan, a novel peripherally acting mu-opioid receptor antagonist, in patients who undergo simple total abdominal hysterectomy...
  14. doi request reprint Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Columbia University, College of Physicians and Surgeons, Irving Cancer Center, New York, NY 10032, USA
    Gynecol Oncol 111:467-73. 2008
    ..To assess the efficacy and toxicity profile in patients with recurrent ovarian or primary peritoneal cancer treated with topotecan at 2.5 mg/m(2) days 1 and 8 plus vinorelbine at 25 mg/m(2) days 1 and 8 every 3 weeks...
  15. doi request reprint How does public policy impact cervical screening and vaccination strategies?
    Thomas J Herzog
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 119:175-80. 2010
    ..To examine the current approaches to cervical screening and points to consider for improving HPV vaccination acceptance and uptake in the US...
  16. ncbi request reprint The role of maintenance therapy and novel taxanes in ovarian cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University, Herbert Irving Cancer Center, 161 Ft Washington Avenue, New York, NY 10032, USA
    Gynecol Oncol 102:218-25. 2006
    ..In addition, the role of novel taxanes, which may offer an improved therapeutic index and reduced toxicity relative to conventional therapies in this setting, is discussed...
  17. doi request reprint Chemosensitivity testing with ChemoFx and overall survival in primary ovarian cancer
    Thomas J Herzog
    Irving Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, New York Presbyterian Hospital, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, New York, NY 10032, USA
    Am J Obstet Gynecol 203:68.e1-6. 2010
    ....
  18. pmc Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history
    Barbara M Buttin
    Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Hum Genet 74:1262-9. 2004
    ..A combination of MSI and immunohistochemistry analyses may be helpful in screening for MSH6 mutation carriers...
  19. ncbi request reprint Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, and The Herbert Irving Comprehensive Cancer Center, New York, New York 10032, USA
    Obstet Gynecol 120:871-81. 2012
    ..Cytoreductive surgery is associated with extensive morbidity and may delay chemotherapy. We examined the associations among cytoreduction, perioperative complications, and delay or omission of chemotherapy...
  20. ncbi request reprint Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET
    Perry W Grigsby
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 61:444-9. 2005
    ..To compare the outcome of patients with cervical cancer and negative lymph nodes by fluorodeoxyglucose-positron emission tomography (FDG-PET) treated with irradiation (RT) and concurrent chemotherapy or RT alone...
  21. doi request reprint Contemporary management of endometrial cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York, NY 10032, USA
    Lancet 379:1352-60. 2012
    ..International cooperation in clinical trials will hasten progress in treatment of this ubiquitous cancer...
  22. doi request reprint Access to conservative surgical therapy for adolescents with benign ovarian masses
    Sloane Berger-Chen
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Obstet Gynecol 119:270-5. 2012
    ..To perform a population-based analysis to determine possible factors associated with use of laparoscopy and ovarian-conserving cystectomy...
  23. ncbi request reprint Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Alvin J Siteman Cancer Center, St Louis, Missouri 63110, USA
    Cancer 104:2484-91. 2005
    ..The objective of this study was to determine the sensitivity and specificity of PET in detecting lymph node metastasis in women with early-stage cervical carcinoma...
  24. ncbi request reprint Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer
    Neil S Horowitz
    Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 95:546-51. 2004
    ....
  25. ncbi request reprint CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer
    Zhengyan Zhang
    Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8064, St Louis, MO 63110, USA
    Cancer Res 67:11202-8. 2007
    ..None of seven nearby genes was differentially expressed in cervical cancer. The importance of CD83 in epithelial versus dendritic cells needs to be determined, as does its role in promoting cervical cancer...
  26. pmc Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer
    Jason D Wright
    Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Clin Oncol 30:783-91. 2012
    ..We performed a population-based analysis to compare laparoscopic hysterectomy and robotic hysterectomy for endometrial cancer...
  27. doi request reprint Defining the limits of radical cytoreductive surgery for ovarian cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, USA
    Gynecol Oncol 123:467-73. 2011
    ..We examined the outcomes of cytoreductive surgery to determine if there are groups of patients in which the morbidity is so substantial that alternate treatment strategies are warranted...
  28. doi request reprint Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome
    Erin M George
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Gynecol Oncol 131:42-5. 2013
    ..Ovarian carcinosarcomas (OCS) are rare tumors composed of both malignant epithelial and mesenchymal elements. We compared the natural history and outcomes of OCS to serous carcinoma of the ovary...
  29. doi request reprint Prognostic significance of adenocarcinoma histology in women with cervical cancer
    Vijaya Galic
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, 8th Floor, New York, NY 10032, United States
    Gynecol Oncol 125:287-91. 2012
    ..We performed a population-based analysis to determine the effect of histology on survival for women with invasive cervical cancer...
  30. doi request reprint Failure to rescue as a source of variation in hospital mortality for ovarian cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, 8th Floor, New York, NY 10032, USA
    J Clin Oncol 30:3976-82. 2012
    ..We examined the role of complications, failure to rescue from complications, and mortality based on hospital volume for ovarian cancer...
  31. doi request reprint Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, Eighth Floor, New York, NY 10032, USA
    JAMA 309:689-98. 2013
    ....
  32. doi request reprint Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Ann Surg Oncol 19:948-58. 2012
    ..We examined the influence of surgeon and hospital case volume on morbidity, mortality, and resource utilization for women with endometrial cancer undergoing laparoscopic hysterectomy...
  33. ncbi request reprint The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model
    Neil S Horowitz
    Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 94:67-73. 2004
    ....
  34. ncbi request reprint CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan
    Gabrielle Gossner
    Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 103:212-8. 2006
    ..In this study, we sought to gain insight into response patterns regarding CA-125 in responders vs. non-responders and to determine whether specific "cut-off" values could help predict ultimate clinical response...
  35. doi request reprint Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer
    Nicanor I Barrena Medel
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Collage of Physicians and Surgeons, 161 Fort Washington Avenue, New York, NY 10032, USA
    Am J Obstet Gynecol 204:248.e1-7. 2011
    ..We examined the prognostic significance of uterine risk factors (RF) compared to nodal metastases in endometrial cancer...
  36. doi request reprint The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study
    John K Chan
    Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94143 1702, USA
    Gynecol Oncol 116:301-6. 2010
    ..three cycles of chemotherapy. We proposed to identify subsets of patients who may benefit from more cycles of chemotherapy...
  37. doi request reprint Morbidity and mortality of surgery for endometrial cancer in the oldest old
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 205:66.e1-8. 2011
    ..Although endometrial cancer commonly occurs in elderly women, little is known about the perioperative outcomes of the oldest women (> 80 years of age) who are treated surgically...
  38. doi request reprint Patterns of care for locally advanced vulvar cancer
    Charu Sharma
    Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, NY
    Am J Obstet Gynecol 209:60.e1-5. 2013
    ..Neoadjuvant treatment appears to be associated with decreased morbidity and acceptable long-term outcomes. We examined the patterns of care for women with locally advanced vulvar cancer...
  39. doi request reprint Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, United States
    Gynecol Oncol 130:43-8. 2013
    ..We examined the use of IMRT and its effect on late toxicity for uterine cancer...
  40. ncbi request reprint Acceptance and compliance with postpartum human papillomavirus vaccination
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, and The Herbert Irving Comprehensive Cancer Center, New York, New York 10032, USA
    Obstet Gynecol 120:771-82. 2012
    ..Despite the efficacy of vaccines against human papillomavirus (HPV), vaccination rates remain low in many countries. We estimated the acceptability and satisfaction of HPV vaccination in postpartum women...
  41. doi request reprint Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy
    Maria B Schiavone
    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 207:382.e1-9. 2012
    ..We examined the use, safety, and economic impact of same-day discharge for women undergoing laparoscopic hysterectomy...
  42. doi request reprint Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer
    Sharyn N Lewin
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, The Herbert Irving Comprehensive Cancer Center, New York, New York, USA
    Obstet Gynecol 116:1141-9. 2010
    ..To perform a population-based analysis comparing the performance of the 1988 and 2009 International Federation of Gynecology and Obstetrics (FIGO) staging systems...
  43. doi request reprint Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer
    Stephanie L Wethington
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Cancer 113:3298-306. 2008
    ..These malignancies are thought to behave biologically and clinically like ovarian cancer. The purpose of this study was to compare the clinical behavior and outcome of fallopian tube and ovarian cancer...
  44. ncbi request reprint Cervical carcinoma in the elderly: an analysis of patterns of care and outcome
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Cancer 103:85-91. 2005
    ..Advanced age often is considered a poor prognostic factor for cervical carcinoma. The authors investigated the patterns of care and treatment outcomes of elderly women with cervical carcinoma...
  45. doi request reprint The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Am J Obstet Gynecol 199:536.e1-8. 2008
    ..We examined the effect of radiation on survival for early-stage uterine carcinosarcomas and leiomyosarcomas...
  46. pmc Failure to rescue after major gynecologic surgery
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, Columbia University, New York, NY Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, Columbia University, New York, NY Electronic address
    Am J Obstet Gynecol 209:420.e1-8. 2013
    ..We examined complications, failure to rescue (death in patients with a complication), and mortality rates for women who underwent abdominal hysterectomy...
  47. doi request reprint Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier
    Shazia Bashir
    1 Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 2 Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 3 Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York 4 Herbert Irving Comprehensive Cancer Center, New York, New York
    Dis Colon Rectum 56:1174-84. 2013
    ..Little is known about the use and toxicity of antiadhesion substances such as sodium hyaluronate-carboxymethylcellulose...
  48. ncbi request reprint Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix
    Binh N Tran
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, St Louis, MO, USA
    Gynecol Oncol 90:572-6. 2003
    ....
  49. doi request reprint Morbidity and mortality of peripartum hysterectomy
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Obstet Gynecol 115:1187-93. 2010
    ..To perform a population-based analysis to examine the morbidity and mortality of peripartum hysterectomy in comparison with nonobstetric hysterectomy...
  50. doi request reprint Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Obstet Gynecol 115:585-90. 2010
    ..To estimate the safety of fertility-conserving surgery for stage IA1 cervical cancer and to analyze predictors of access to conization...
  51. ncbi request reprint Detection and significance of parametrial micrometastases in early-stage cervical cancer
    Paula C Brady
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Anticancer Res 31:243-7. 2011
    ..Parametrial metastases are rare in women with small, node-negative cervical tumors. We examined the incidence of micrometastases in women with pathologically negative parametria...
  52. doi request reprint The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies
    Nisha Bansal
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 111:208-12. 2008
    ..To determine the utility and cost effectiveness of preoperative computed tomography (CT) in detecting disease extent in patients with uterine carcinoma...
  53. doi request reprint Endometrial cancer in the oldest old: Tumor characteristics, patterns of care, and outcome
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 122:69-74. 2011
    ..We examined the patterns of care and outcome of the oldest old women with endometrial cancer...
  54. doi request reprint Optimizing the management of stage II endometrial cancer: the role of radical hysterectomy and radiation
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Am J Obstet Gynecol 200:419.e1-7. 2009
    ..The optimal management of stage II endometrial cancer remains uncertain. We examined the role of radical hysterectomy and adjuvant radiotherapy for stage II endometrial cancer...
  55. doi request reprint Sarcoma of the cervix: natural history and outcomes
    Sharmilee Bansal
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, New York, NY 10032, USA
    Gynecol Oncol 118:134-8. 2010
    ..In addition, we examined the prognostic significance of various demographic, clinical, and treatment related factors...
  56. ncbi request reprint Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation
    Barbara M Buttin
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Cancer Res 10:481-90. 2004
    ..The aim of this study was to evaluate number and types of synchronous and metachronous malignancies in patients with endometrial carcinoma with and without microsatellite instability (MSI)...
  57. doi request reprint Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer
    Charu Sharma
    Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 205:562.e1-9. 2011
    ..We analyzed the effect of lymphadenectomy on the use of adjuvant radiation treatment for women with stage I-II endometrial cancer...
  58. doi request reprint Predictors of massive blood loss in women with placenta accreta
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 205:38.e1-6. 2011
    ..We examined predictors of massive blood loss for women with placenta accreta who had undergone hysterectomy...
  59. ncbi request reprint Safety of conservative management of ovarian masses during pregnancy
    Paula C Brady
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Avenue, 8th Floor, New York, NY 10032, USA
    J Reprod Med 58:377-82. 2013
    ..To determine the clinical outcomes and risk factors for persistence of ovarian cysts in pregnant women. With the increased use of ultrasound in pregnancy, the identification of incidental ovarian masses is becoming more common...
  60. doi request reprint Effect of surgical volume on morbidity and mortality of abdominal hysterectomy for endometrial cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Obstet Gynecol 117:1051-9. 2011
    ..To estimate the effects of surgeon and hospital volume on perioperative morbidity and mortality in women who underwent hysterectomy for endometrial cancer...
  61. doi request reprint Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy
    Jessica M B Ritch
    Division of Gynecologic Oncology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Obstet Gynecol 117:1367-74. 2011
    ..To examine the risk of venous thromboembolism and the use of venous thromboembolism prophylaxis in women undergoing laparoscopic hysterectomy...
  62. doi request reprint Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 127:11-7. 2012
    ..We analyzed the uptake, morbidity, and cost of laparoscopic and robotic radical hysterectomies for cervical cancer...
  63. doi request reprint Patterns of care and treatment outcomes for elderly women with cervical cancer
    Charu Sharma
    Department of Radiation Oncology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Cancer 118:3618-26. 2012
    ..Cervical cancer is common in the elderly. The authors examined the patterns of care, treatment, and outcomes of elderly women with cervical cancer...
  64. doi request reprint Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications
    Michelle R Wallenstein
    Department of Obstetrics, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Obstet Gynecol 119:709-16. 2012
    ..To estimate the influence of surgical volume on outcome and resource utilization for laparoscopic hysterectomy for benign indications...
  65. doi request reprint Microinvasive adenocarcinoma of the cervix
    Lori Spoozak
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 206:80.e1-6. 2012
    ..We compared the outcomes of microinvasive squamous cell carcinoma and adenocarcinoma of the cervix and examined the safety of fertility-conserving treatment...
  66. ncbi request reprint Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes Hospital Plaza, Box 8064, St Louis, MO 63110, USA
    Gynecol Oncol 98:84-91. 2005
    ..The aim of this study was to define the prognostic significance of HPV 18 and its phylogenetically related viruses and smoking on survival in patients with early stage cervical cancer...
  67. doi request reprint Long-term outcome and natural history of uterine adenosarcomas
    Rebecca Arend
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgenos, New York, NY 10032, USA
    Gynecol Oncol 119:305-8. 2010
    ..We examined the natural history of uterine adenosarcomas and compared the outcome of uterine adenosarcoma and carcinosarcoma...
  68. ncbi request reprint Relationship of ovarian neoplasms and body mass index
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    J Reprod Med 50:595-602. 2005
    ..To describe the distribution of benign and malignant ovarian neoplasms among overweight and obese women...
  69. doi request reprint Natural history and outcome of mucinous carcinoma of the ovary
    Maria B Schiavone
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Am J Obstet Gynecol 205:480.e1-8. 2011
    ..We performed a population-based analysis to compare the clinical characteristics of women with mucinous tumors with women with other epithelial tumors...
  70. doi request reprint Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study
    Jason D Wright
    Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Gynecol Oncol 109:353-8. 2008
    ..Obese women may therefore receive a sub-therapeutic carboplatin dose. This study assessed the association between BMI and outcome for ovarian cancer patients treated with carboplatin-based chemotherapy...
  71. ncbi request reprint Early metastatic spread after a complete response in locally advanced vulvar cancer treated with neoadjuvant chemoradiation: a case report
    Nisha Bansal
    Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York, USA
    J Reprod Med 53:700-2. 2008
    ..Preoperative chemoradiation for advanced vulvar cancer reduces the tumor size and decreases morbidity from operative resection...
  72. pmc Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes
    Jason D Wright
    Division of Gynecologic Oncology, Departments of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    JAMA Intern Med 173:559-68. 2013
    ..Although febrile neutropenia (FN) is a major source of morbidity and mortality for patients with solid tumors, little is known about the use of guideline-based care...
  73. doi request reprint The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals
    Maria B Schiavone
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 207:174.e1-7. 2012
    ..We analyzed the content, quality, and accuracy of information provided on hospital web sites about robotic gynecologic surgery...
  74. ncbi request reprint A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer
    Kathleen N Moore
    University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd WP 2470, Oklahoma City, OK 73014, and Washington University Barnes Jewish Christian Hospitals, St Louis, MO, USA
    Gynecol Oncol 105:299-303. 2007
    ..The objective of this study was to compare response rate and survival in patients with cervical cancer treated with PT or CT...
  75. ncbi request reprint Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin
    Sharyn N Lewin
    Division of Gynecologic Oncology, Washington University School of Medicine, 4911 Barnes Jewish Hospital Plaza, Box 8064, St Louis, MO 63110 1094, USA
    Gynecol Oncol 97:228-33. 2005
    ..To our knowledge, no case reports of HUS in ovarian cancer patients receiving treatment with combination gemcitabine and pegylated liposomal doxorubicin (PLD) have been reported...
  76. ncbi request reprint FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma
    Anurag K Singh
    Department of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 56:489-93. 2003
    ....
  77. ncbi request reprint Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 94:436-41. 2004
    ..The goal of this study was to determine the effect of panniculectomy on staging adequacy and lymph node yield in obese women with endometrial carcinoma undergoing staging laparotomy...
  78. ncbi request reprint Hemolytic uremic syndrome presenting after treatment of endodermal sinus tumor
    Dele A Ogunleye
    Department of Obstetrics and Gynecology, Good Samaritan Hospital, Cincinnati, Ohio, USA
    Obstet Gynecol 104:1184-7. 2004
    ..Hemolytic uremic syndrome is a rare multisystem disorder that is caused by infections, preeclampsia, autoimmune disorders, or oral contraceptive agents, and rarely in association with different cancers and chemotherapeutic agents...
  79. doi request reprint Risk and predictors of malignancy in women with endometrial polyps
    Stephanie L Wethington
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Ann Surg Oncol 18:3819-23. 2011
    ..Consensus guidelines to direct the management of women with endometrial polyps are lacking. We examined the risk of malignancy in symptomatic and asymptomatic women with endometrial polyps...
  80. doi request reprint The influence of surgical volume on morbidity and mortality of radical hysterectomy for cervical cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA
    Am J Obstet Gynecol 205:225.e1-7. 2011
    ..We examined the influence of physician and hospital volume on the morbidity and mortality of radical hysterectomy for cervical cancer...
  81. doi request reprint Therapeutic role of lymphadenectomy for cervical cancer
    Monjri Shah
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Cancer 117:310-7. 2011
    ..Despite the diagnostic value of lymphadenectomy for early-stage cervical cancer, its therapeutic role is unknown. We examined the therapeutic potential of extensive lymphadenectomy in women with early-stage cervical cancer...
  82. doi request reprint Adherence to evidence-based guidelines for preoperative testing in women undergoing gynecologic surgery
    Caryn M St Clair
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Obstet Gynecol 116:694-700. 2010
    ..To examine adherence to evidence-based recommendations for preoperative testing and health care costs associated with excessive testing...
  83. doi request reprint Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery
    Jason D Wright
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Obstet Gynecol 118:978-86. 2011
    ..To estimate the use of venous thromboembolism prophylaxis in women undergoing gynecologic surgery and to estimate the patient, physician, and hospital characteristics associated with guideline-based prophylaxis...
  84. doi request reprint Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Cancer 116:2486-92. 2010
    ..The goal of the current study was to examine the risk of treatment-associated leukemia and multiple myeloma in patients treated with pelvic radiotherapy...
  85. ncbi request reprint Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study
    Katherine Y Look
    Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    Gynecol Oncol 92:93-100. 2004
    ....
  86. ncbi request reprint Synchronous ovarian metastases at the time of laparotomy for colon cancer
    Jason D Wright
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 92:851-5. 2004
    ..The aim of the study was to identify clinical features, define prognostic factors and optimize treatment in patients with colorectal cancer with synchronous ovarian metastases at the time of initial diagnosis...
  87. doi request reprint Safety of ovarian preservation in premenopausal women with endometrial cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, 8th Floor, New York, NY 10032, USA
    J Clin Oncol 27:1214-9. 2009
    ..We examined the safety of ovarian preservation in young women with endometrial cancer who underwent hysterectomy...
  88. ncbi request reprint Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 91:134-8. 2003
    ..To determine the performance of liquid-based cytology using ThinPrep in the postirradiation surveillance of women with gynecologic malignancies...
  89. ncbi request reprint Morbidity of cytoreductive surgery in the elderly
    Jason D Wright
    Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Am J Obstet Gynecol 190:1398-400. 2004
    ..While ovarian cancer is often seen in elderly patients, such women are often not treated as aggressively as younger patients. In this study, we evaluated the feasibility and morbidity of cytoreductive surgery in the elderly...
  90. ncbi request reprint Update on the role of topotecan in the treatment of recurrent ovarian cancer
    Thomas J Herzog
    University Medical Center, Washington University School of Medicine, 4911 Barnes Jewish Hospital Plaza, 3rd Floor, St Louis, MO 63110 1094, USA
    Oncologist 7:3-10. 2002
    ..Further studies with topotecan alone and in combination with other agents are needed to fully characterize the role and sequencing of topotecan in the salvage and first-line settings...
  91. doi request reprint Fertility preservation in young women with epithelial ovarian cancer
    Jason D Wright
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, and Herbert Irving Comprehensive Cancer Center, New York Presbyterian Hospital, New York, New York 10032, USA
    Cancer 115:4118-26. 2009
    ..In young women, this results in the loss of reproductive function and estrogen deprivation. In the current study, the authors examined the safety of fertility-conserving surgery in premenopausal women with epithelial ovarian cancers...
  92. ncbi request reprint Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Sharyn N Lewin
    Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, USA
    Gynecol Oncol 99:261-6. 2005
    ..The goal of this study was to compare the total cost of hospital-based resources utilized in ovarian cancer patients during their last 60 days of life for those enrolled in hospice versus those not on hospice...
  93. ncbi request reprint Epithelial ovarian tumors of low malignant potential: the role of microinvasion
    Barbara M Buttin
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri, USA
    Obstet Gynecol 99:11-7. 2002
    ..To identify prognostic factors that may be used to predict an aggressive disease course and poor outcome in patients with epithelial ovarian tumors of low malignant potential (borderline tumors)...
  94. ncbi request reprint Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line
    Jun Hua
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, Box 8064, 4911 Barnes Hospital Plaza, St Louis, MO 63110, USA
    Gynecol Oncol 98:31-8. 2005
    ..The impact of transfecting the RNAi upon MDR-1 mRNA and P-glycoprotein expression as well as resultant chemotherapy resistance was assessed...
  95. doi request reprint Stage IIIA endometrial carcinoma: outcome and predictors of survival
    Sharmilee Bansal
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Obstet Gynecol 114:100-5. 2009
    ..To examine predictors of survival for stage IIIA endometrial cancer and to compare the outcome of stage IIIA neoplasms to that of endometrial tumors confined to the uterus...
  96. ncbi request reprint Natural history of established low grade cervical intraepithelial (CIN 1) lesions
    Nisha Bansal
    Columbia University College of Physicians and Surgeons, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, New York, NY 10032, USA
    Anticancer Res 28:1763-6. 2008
    ..THE AIM of the present study was to ascertain the natural history of cervical intraepithelial lesions 1 (CIN 1) and to develop recommendations to optimize follow-up...
  97. ncbi request reprint Clinical experience with topotecan in relapsed ovarian cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Washington University Medical Center, St Louis, MO 63110, USA
    Gynecol Oncol 90:S3-7. 2003
    ..Optimization of the use of topotecan may offer potential opportunities for further improving the management of ovarian cancer...
  98. pmc Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers
    Paul J Goodfellow
    Department of Surgery, Washington University School of Medicine, Campus Box 8109, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 100:5908-13. 2003
    ..The minimum estimate of the prevalence of inherited MSH6 mutation in endometrial cancer is 1.6% (7 of 441), comparable with the predicted prevalence for patients with colorectal cancer...
  99. ncbi request reprint Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma
    Bradford P Whitcomb
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Clin Cancer Res 9:2277-87. 2003
    ..This study was designed to determine whether there is a methylator phenotype in stage I and II endometrioid endometrial adenocarcinoma, and if so, whether methylation correlates with recurrence...
  100. doi request reprint Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation
    Nisha Bansal
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Am J Obstet Gynecol 201:485.e1-9. 2009
    ..We compared survival for women with early-stage cervical cancer who were treated with primary radiation or radical hysterectomy...
  101. ncbi request reprint Workshop: options for therapy in ovarian cancer
    Thomas J Herzog
    Division of Gynecologic Oncology, Washington University Medical Center, St Louis, MO 63110, USA
    Gynecol Oncol 90:S45-50. 2003
    ..The progression-free interval may be extended by continuing topotecan until disease progression in patients with stable disease or by topotecan consolidation therapy in treatment responders...